181 related articles for article (PubMed ID: 32703715)
41. Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study.
Downing A; Wright P; Hounsome L; Selby P; Wilding S; Watson E; Wagland R; Kind P; Donnelly DW; Butcher H; Catto JWF; Cross W; Mason M; Sharp L; Weller D; Velikova G; McCaughan E; Mottram R; Allen M; Kearney T; McSorley O; Huws DW; Brewster DH; McNair E; Gavin A; Glaser AW
Lancet Oncol; 2019 Mar; 20(3):436-447. PubMed ID: 30713036
[TBL] [Abstract][Full Text] [Related]
42. Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial.
Nabid A; Carrier N; Martin AG; Bahary JP; Lemaire C; Vass S; Bahoric B; Archambault R; Vincent F; Bettahar R; Duclos M; Garant MP; Souhami L
Eur Urol; 2018 Oct; 74(4):432-441. PubMed ID: 29980331
[TBL] [Abstract][Full Text] [Related]
43. Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia.
Baade PD; Youlden DR; Gardiner RA; Ferguson M; Aitken JF; Yaxley J; Chambers SK
BJU Int; 2012 Dec; 110(11 Pt B):E712-9. PubMed ID: 23017157
[TBL] [Abstract][Full Text] [Related]
44. Depressive symptoms are found to be potential adverse effects of androgen deprivation therapy in older prostate cancer patients: A 15-month prospective, observational study.
Zhang Z; Yang L; Xie D; Shi H; Li G; Yu D
Psychooncology; 2017 Dec; 26(12):2238-2244. PubMed ID: 28474429
[TBL] [Abstract][Full Text] [Related]
45. Nutrition therapy with high intensity interval training to improve prostate cancer-related fatigue in men on androgen deprivation therapy: a study protocol.
Baguley BJ; Skinner TL; Leveritt MD; Wright OR
BMC Cancer; 2017 Jan; 17(1):1. PubMed ID: 28049525
[TBL] [Abstract][Full Text] [Related]
46. Psychosocial interventions for men with prostate cancer.
Parahoo K; McDonough S; McCaughan E; Noyes J; Semple C; Halstead EJ; Neuberger MM; Dahm P
Cochrane Database Syst Rev; 2013 Dec; (12):CD008529. PubMed ID: 24368598
[TBL] [Abstract][Full Text] [Related]
47. Symptom experiences of older adults during treatment for metastatic prostate cancer: A qualitative investigation.
Parthipan M; Feng G; Toledano N; Donison V; Breunis H; Sudharshan A; Emmenegger U; Finelli A; Warde P; Soto-Perez-de-Celis E; Krzyzanowska M; Matthew A; Clarke H; Mina DS; Alibhai SMH; Puts M
J Geriatr Oncol; 2023 Jan; 14(1):101397. PubMed ID: 36988104
[TBL] [Abstract][Full Text] [Related]
48. Effects of Androgen Deprivation Therapy on Pain Perception, Quality of Life, and Depression in Men With Prostate Cancer.
Gagliano-Jucá T; Travison TG; Nguyen PL; Kantoff PW; Taplin ME; Kibel AS; Manley R; Hally K; Bearup R; Beleva YM; Huang G; Edwards RR; Basaria S
J Pain Symptom Manage; 2018 Feb; 55(2):307-317.e1. PubMed ID: 28941963
[TBL] [Abstract][Full Text] [Related]
49. Efficacy of a multi-component exercise programme and nutritional supplementation on musculoskeletal health in men treated with androgen deprivation therapy for prostate cancer (IMPACT): study protocol of a randomised controlled trial.
Owen PJ; Daly RM; Livingston PM; Mundell NL; Dalla Via J; Millar JL; Fraser SF
Trials; 2017 Oct; 18(1):451. PubMed ID: 28974267
[TBL] [Abstract][Full Text] [Related]
50. Psychological effects of androgen-deprivation therapy on men with prostate cancer and their partners.
Donovan KA; Walker LM; Wassersug RJ; Thompson LM; Robinson JW
Cancer; 2015 Dec; 121(24):4286-99. PubMed ID: 26372364
[TBL] [Abstract][Full Text] [Related]
51. Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective study.
Mazariego CG; Egger S; King MT; Juraskova I; Woo H; Berry M; Armstrong BK; Smith DP
BMJ; 2020 Oct; 371():m3503. PubMed ID: 33028540
[TBL] [Abstract][Full Text] [Related]
52. Experiences and supportive care needs of UK patients with pancreatic cancer: a cross-sectional questionnaire survey.
Watson EK; Brett J; Hay H; Witwicki C; Perris A; Poots AJ; Sizmur S; Soonawalla Z; Tallett A
BMJ Open; 2019 Nov; 9(11):e032681. PubMed ID: 31690609
[TBL] [Abstract][Full Text] [Related]
53. Quality of life effects of androgen deprivation therapy in a prostate cancer cohort in New Zealand: can we minimize effects using a stratification based on the aldo-keto reductase family 1, member C3 rs12529 gene polymorphism?
Karunasinghe N; Zhu Y; Han DY; Lange K; Zhu S; Wang A; Ellett S; Masters J; Goudie M; Keogh J; Benjamin B; Holmes M; Ferguson LR
BMC Urol; 2016 Aug; 16(1):48. PubMed ID: 27485119
[TBL] [Abstract][Full Text] [Related]
54. Mapping unmet supportive care needs, quality-of-life perceptions and current symptoms in cancer survivors across the Asia-Pacific region: results from the International STEP Study.
Molassiotis A; Yates P; Li Q; So WKW; Pongthavornkamol K; Pittayapan P; Komatsu H; Thandar M; Yi M; Titus Chacko S; Lopez V; Butcon J; Wyld D; Chan RJ;
Ann Oncol; 2017 Oct; 28(10):2552-2558. PubMed ID: 28961835
[TBL] [Abstract][Full Text] [Related]
55. Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate cancer.
DiBlasio CJ; Hammett J; Malcolm JB; Judge BA; Womack JH; Kincade MC; Ogles ML; Mancini JG; Patterson AL; Wake RW; Derweesh IH
Can J Urol; 2008 Oct; 15(5):4249-56; discussion 4256. PubMed ID: 18814813
[TBL] [Abstract][Full Text] [Related]
56. The supportive care needs for prostate cancer patients in Sarawak.
Cheah WL; Ling NC; Chang KH
Chin Clin Oncol; 2016 Feb; 5(1):7. PubMed ID: 26932431
[TBL] [Abstract][Full Text] [Related]
57. A systematic review of the unmet supportive care needs of men on active surveillance for prostate cancer.
McIntosh M; Opozda MJ; Evans H; Finlay A; Galvão DA; Chambers SK; Short CE
Psychooncology; 2019 Dec; 28(12):2307-2322. PubMed ID: 31663180
[TBL] [Abstract][Full Text] [Related]
58. Psychological distress in men with prostate cancer undertaking androgen deprivation therapy: modifying effects of exercise from a year-long randomized controlled trial.
Galvão DA; Newton RU; Chambers SK; Spry N; Joseph D; Gardiner RA; Fairman CM; Taaffe DR
Prostate Cancer Prostatic Dis; 2021 Sep; 24(3):758-766. PubMed ID: 33558661
[TBL] [Abstract][Full Text] [Related]
59. Relationships among unmet needs, depression, and anxiety in non-advanced cancer patients.
Ferrari M; Ripamonti CI; Hulbert-Williams NJ; Miccinesi G
Tumori; 2019 Apr; 105(2):144-150. PubMed ID: 29714666
[TBL] [Abstract][Full Text] [Related]
60. Neuropsychiatric Impact of Androgen Deprivation Therapy in Patients with Prostate Cancer: Current Evidence and Recommendations for the Clinician.
Siebert AL; Lapping-Carr L; Morgans AK
Eur Urol Focus; 2020 Nov; 6(6):1170-1179. PubMed ID: 32690473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
